Skip to main content

Day: July 6, 2020

Téléconférence sur les résultats du deuxième trimestre 2020

AURORA, Ontario, 06 juill. 2020 (GLOBE NEWSWIRE) — Magna International Inc. (TSX :MG) (NYSE :MGA)INVESTOR CONTACTLouis Tonelli, vice-président, relations avec les investisseurslouis.tonelli@magna.com    905-726-7035TELECONFERENCE CONTACTNancy Hansford, assistante de direction, relations avec les investisseursnancy.hansford@magna.com    905-726-7108

Continue reading

Aptean Announces the Acquisition of DIN Solutions, Strengthening its Leadership in the Food and Beverage ERP Market

ALPHARETTA, Ga., July 06, 2020 (GLOBE NEWSWIRE) — Today, Aptean, a global provider of mission-critical enterprise software solutions, announced the acquisition of Netherlands-based DIN Solutions, a full-service provider of specialized food and beverage enterprise resource planning (ERP) solutions for middle-market organizations in the Benelux region.Founded in 1982, DIN Solutions delivers purpose-built cloud software with the ability to scale on demand and meet the ever-evolving needs of its customers. Serving as a complement to Aptean’s recent acquisition of Schouw Informatisering, DIN Solutions has leading capabilities that streamline and process data with high efficiency, ensuring deeper transparency into the supply chain. Further, this purchase reinforces Aptean’s robust capabilities for the food and beverage industry, expands...

Continue reading

Aptean kondigt de overname van DIN Solutions aan en versterkt haar leiderschap in de Food&Beverage ERP markt

ALPHARETTA, Ga., July 06, 2020 (GLOBE NEWSWIRE) — Vandaag kondigde Aptean, wereldwijde leverancier van bedrijfskritische software oplossingen, de overname aan van het in Nederland gevestigde DIN Solutions, een full-service ERP leverancier voor bedrijven in de voedingsmiddelen- en drankenindustrie in de Benelux.DIN Solutions, opgericht in 1982, levert branchegerichte, cloud software afgestemd op de steeds veranderende behoeften van de markt en haar klanten. Als aanvulling op Aptean’s recente overname van Schouw Informatisering, heeft DIN Solutions toonaangevende oplossingen om data te stroomlijnen, efficiënt te verwerken en een transparantere supply chain te realiseren. Verder versterkt deze acquisitie de robuuste mogelijkheden van Aptean voor de voedingsmiddelen- en drankenindustrie, breidt het zijn SaaS-aanbod uit en vergroot het...

Continue reading

Connectyx in Licensing Discussions for Novel Monoclonal Antibody to Treat Pediatric Glioblastoma

Boca Raton, FL, July 06, 2020 (GLOBE NEWSWIRE) — Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel treatments for rare diseases today announced it is in licensing discussions for a novel monoclonal antibody (mAB) to treat brain cancer. The Company plans to grow its product pipeline through an active program of acquisition, in-licensing and sub-licensing of new technologies.Connectyx has evaluated hundreds of available pharmaceutical assets, and the management, along with the Scientific Advisory Board, have identified a novel mAB available for license to treat pediatric glioblastoma. Pediatric glioblastoma (also sometimes called grade IV astrocytoma) is a malignant brain tumor that is aggressive and without a defined standard therapy. The...

Continue reading

Tactical Data Link Market Size to Reach USD 9.88 Billion by 2027; Applications in Military and Defense Sector Will Aid Growth, says Fortune Business Insights™

Pune, July 06, 2020 (GLOBE NEWSWIRE) — The global tactical data link market size is projected to reach USD 9.88 billion by the end of 2027. The increasing investment in technological intervention will emerge in favor of market growth. According to a report published by Fortune Business Insights, titled “Tactical Data Link Market Size, Share and Covid-19 Impact Analysis, by Solution (Hardware, and Software), By Platform (Air, Ground, and Sea), By Application (Command & Control, Intelligence, Surveillance & Reconnaissance (ISR), Electronic Warfare, Radio Communication, and Situational Awareness), and Regional Forecast, 2020 – 2027,” the market was worth USD 6.14 billion in 2019 and will exhibit a CAGR of 9.54% during the forecast period, 2020-2027. The novel coronavirus, COVID-19, has cast an unprecedented effect on...

Continue reading

Neovasc Provides Update on Second Quarter Results

Company to Report Full Financial Results on August 6, 2020VANCOUVER and MINNEAPOLIS, MN, July 06, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc, Inc. (NASDAQ, TSX: NVCN) today announced preliminary revenue results for the second quarter of 2020. Revenue for the quarter ended June 30, 2020 was approximately $295,000. Revenues were negatively impacted by a reduction in Reducer procedures that began in mid-March and persisted through early June. Despite a marked slowdown in the number of implants and related revenue from the Reducer because of COVID-19, the Company has seen a significant recovery culminating in the highest monthly number of implants in the history of the Company during June.“We are encouraged to see Reducer cases among the earliest elective procedures to resume in Europe, supporting our thesis of strong...

Continue reading

CTG Appoints Brett Hunt to Lead North American Solutions Team

BUFFALO, N.Y., July 06, 2020 (GLOBE NEWSWIRE) — CTG (NASDAQ: CTG), a leading provider of information technology solutions and services in North America and Western Europe, announced today that Brett Hunt has joined CTG as Managing Director of Solutions, North America. In this critical role, Hunt will help to drive accelerated growth of the Company’s Solutions business through the development of key partnerships while spearheading the rapid adoption of CTG’s Delivery Center model. Hunt has over 20 years of IT solutions and services experience with specific expertise in emerging technologies.“We are extremely happy to have Brett join the CTG North American team,” said Tom Niehaus, Executive Vice President, North America. “His extensive experience in developing third-party partnerships and directing global delivery teams, along with...

Continue reading

LPL Financial Welcomes CenterPoint Wealth Advisors

CHARLOTTE, N.C., July 06, 2020 (GLOBE NEWSWIRE) — LPL Financial LLC, a leading retail investment advisory firm, independent broker-dealer and registered investment advisor (RIA) custodian, today announced that Glenn Drake CFP® and John Kinzer CFP® have joined LPL Financial’s broker-dealer and corporate registered investment advisor (RIA) platforms, leveraging LPL as custodian.  They reported having served approximately $225 million in brokerage and advisory assets*. They join from Wells Fargo Financial Advisors Network.Drake and Kinzer are managing partners of CenterPoint Wealth Advisors, based in Crownsville, Md., just outside of Annapolis. The seasoned advisors partnered in 2003 and have more than 60 years combined experience in the industry. “We share the same core beliefs and approach to working with our clients, but we each...

Continue reading

Adverum Biotechnologies Announces Completion of Patient Dosing in Cohort 4 of the OPTIC Phase 1 Trial of ADVM-022 Single Injection Gene Therapy for Wet AMD

— Patients in Cohort 4 received ADVM-022 high dose 6×1011 vg and prophylactic steroid eye drops —— Data from all four cohorts planned by the end of 2020 —REDWOOD CITY, Calif., July 06, 2020 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the completion of patient dosing in Cohort 4 of OPTIC, a Phase 1 clinical trial, assessing a single intravitreal (IVT) injection of ADVM-022 in patients with wet age-related macular degeneration (AMD). Wet AMD is a leading cause of vision loss in patients over 60 years of age, with a prevalence of approximately 1.2 million individuals in the U.S. and 3 million worldwide.“The excitement in the retina community around the OPTIC clinical trial...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.